The Biotech Growth Trust Plc - Transaction in Own Shares
PR Newswire
London, August 10
For immediate release
10 August 2018
THE BIOTECH GROWTH TRUST PLC
(the "Company")
MARKET PURCHASE OF COMPANY'S OWN SHARES
Notification is given, pursuant to the authority granted at the Annual General Meeting of the Company held 11 July 2018 to make market purchases of the Company's own shares up to an aggregate maximum of 8,356,271 that a market total of 154,654 Ordinary shares of 25p each in the capital of the Company were purchased on Friday, 10 August 2018 for cancellation by the Company at a price of 815.78 pence per share.
Following this transaction and in conformity with the provisions of the Transparency Directive, the Company hereby notifies the market that the total number of Ordinary shares that the Company has in issue, less the total number of Ordinary shares bought back for cancellation by the Company following such purchase, and therefore, the total number of voting rights in the Company is 55,170,285. The Company does not currently hold any Ordinary shares in treasury.
The figure of 55,170,285 may be used by shareholders as the denominator for the calculation by which they may determine if they are required to notify their interest in, or change to their interest in, the Company under the FCA's Disclosure and Transparency Rules.
For and on behalf of
Frostrow Capital LLP
Company Secretary
For further information, please contact:
Mark Pope
Frostrow Capital LLP
Tel: 020 3 170 4913
